Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS).
Jacobelli
S
S
André
M
M
Alexandra
J-F
JF
Dodé
C
C
Papo
T
T
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D000068800:Etanercept; D010505:Familial Mediterranean Fever / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D000069285:Infliximab; D008297:Male; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000037:antagonists & inhibitors* / Q000378:metabolism; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D000069285:Infliximab; D000068800:Etanercept